Demyelination as a result of an immune response in patients with COVID-19

Z Shabani - Acta Neurologica Belgica, 2021 - Springer
The coronavirus disease of 2019 (COVID-19) is caused by the severe acute respiratory
syndrome coronavirus-2 (SARS CoV-2), that already appeared as a global pandemic …

Nrf2 activation putatively mediates clinical benefits of low-dose radiotherapy in COVID-19 pneumonia and acute respiratory distress syndrome (ARDS): Novel …

EJ Calabrese, WJ Kozumbo, R Kapoor… - Radiotherapy and …, 2021 - Elsevier
Novel mechanistic insights are discussed herein that link a single, nontoxic, low-dose
radiotherapy (LDRT) treatment (0.5–1.0 Gy) to (1) beneficial subcellular effects mediated by …

Low-dose radiation therapy in the management of coronavirus disease 2019 (COVID-19) pneumonia (LOWRAD-Cov19): Preliminary report

N Sanmamed, P Alcantara, E Cerezo… - International Journal of …, 2021 - Elsevier
Purpose Low-dose radiation therapy (LD-RT) has been shown to have an anti-inflammatory
effect, and preliminary results suggest it is feasible to treat patients with coronavirus disease …

Low-dose whole-lung irradiation for COVID-19 pneumonia: Final results of a pilot study

A Ameri, P Ameri, N Rahnama, M Mokhtari… - International Journal of …, 2021 - Elsevier
Introduction Radiation therapy (RT), commonly used in cancer management, has been
considered as one of the potential treatments for COVID-19 pneumonia. Here, we present …

Immunomodulatory low-dose whole-lung radiation for patients with coronavirus disease 2019-related pneumonia

CB Hess, TH Nasti, VR Dhere, TJ Kleber… - International Journal of …, 2021 - Elsevier
Purpose Phase 1 clinical trials have established low-dose, whole-lung radiation therapy (LD-
RT) as safe for patients with coronavirus disease 2019 (COVID-19)-related pneumonia. By …

Low-dose radiation therapy for COVID-19 pneumonia: a pilot study

DN Sharma, R Guleria, N Wig, A Mohan… - The British journal of …, 2021 - academic.oup.com
Objectives: The World Health Organization (WHO) has declared coronavirus disease 2019
(COVID-19) as pandemic in March 2020. Currently there is no specific effective treatment for …

Low-dose radiation therapy (LDRT) for COVID-19: Benefits or risks?

PG Prasanna, GE Woloschak, AL DiCarlo… - Radiation …, 2020 - meridian.allenpress.com
The limited impact of treatments for COVID-19 has stimulated several phase 1 clinical trials
of whole-lung low-dose radiation therapy (LDRT; 0.3–1.5 Gy) that are now progressing to …

Could pulmonary low-dose radiation therapy be an alternative treatment for patients with COVID-19 pneumonia? Preliminary results of a multicenter SEOR-GICOR …

M Arenas, M Algara, G De Febrer, C Rubio… - Strahlentherapie und …, 2021 - Springer
Purpose To evaluate the efficacy and safety of lung low-dose radiation therapy (LD-RT) for
pneumonia in patients with coronavirus disease 2019 (COVID-19). Materials and methods …

Covid-19 and radiotherapy: a systematic review after 2 years of pandemic

A Piras, V Venuti, A D'Aviero, D Cusumano… - Clinical and translational …, 2022 - Springer
Abstract Introduction Following the Covid-19 pandemic spread, changes in clinical practice
were necessary to limit the pandemic diffusion. Also, oncological practice has undergone …

Effects of COVID-19 on arrhythmia

Y Zhan, H Yue, W Liang, Z Wu - Journal of Cardiovascular Development …, 2022 - mdpi.com
The World Health Organization announced that COVID-19, with SARS-CoV-2 as its
pathogen, had become a pandemic on 11 March 2020. Today, the global epidemic situation …